The airway clearance devices system market is anticipated to flourish at a healthy CAGR of 6.2% between 2023 and 2033. The market is expected to hold a market share of USD 1137.2 million by 2033 while the market is likely to reach a value of USD 624.5 million in 2023.
Airway Clearance techniques (ACTs) are treatment methods that help people suffering from disorders such as cystic fibrosis attain a healthy lifestyle. ACTs are physical or mechanical means of simplifying the elimination of tracheobronchial phlegm through the external or internal management of airflow, and the removal of phlegm via coughing.
Airway clearance devices loosen thick, sticky lung mucus so it can be cleared by coughing. Clearing the mucus from the airways helps in reducing lung infections and improves lung function. Additionally, these airway clearance devices find their application in the treatment of various disorders including emphysema, cystic fibrosis, neuromuscular, bronchiectasis, and others.
Increasing product upgrades by prominent medical device companies are expected to drive the market at an unprecedented rate throughout the forecast period. For example,
The limited availability of evidence-based data for the effectiveness of devices is a key factor that is expected to impede the growth of the airway clearance devices system market during the forecast period.
| Attributes | Details |
|---|---|
| Airway Clearance Devices System Market CAGR (2023 to 2033) | 6.2% |
| Airway Clearance Devices System Market Size (2023) | USD 624.5 million |
| Airway Clearance Devices System Market Size (2033) | USD 1137.2 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing Cases of Cystic Fibrosis, Asthma, and Other Respiratory Orders to Augment the Market
The surge in the prevalence of cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD) across the world is the key factor that is expected to boost the growth of the airway clearance system market. A few other factors driving the market growth are increasing concerns about respiratory diseases, such as asthma and emphysema, and the rising incidence of respiratory diseases caused due to cigarette consumption.
Factors such as an increase in healthcare expenditure, growth in the use of automation in the healthcare industry, and rapid adoption of advanced medical solutions are expected to propel the market growth over the analysis period. Additionally, most healthcare practitioners and pulmonary diseases specialists prefer a combination of a drug and a device like an inhaler and nebulizer, owing to their fast and effective outcome.
Favorable insurance coverage offered by the governments and private companies for the usage of airway clearance systems for these respiratory diseases, especially in developed economies expected to bode well for market growth. Also, companies like Electromed, Inc., and Hill-Rom offer effective treatment as well as easy reimbursement.
Rising patient awareness for creating a common platform for COPD patients is anticipated to drive market growth over the forecast period. For example,
High Costs Associated with Airway Clearance to Hamper the Market
The limited availability of evidence-based data for the effectiveness of devices is a major factor that is expected to impede the growth of the airway clearance devices system market during the forecast period.
Additionally, the airway clearance system market growth could be hampered, due to factors such as high cost associated with the airway clearance systems and side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.
Principal Consultant
| Countries | Revenue Share % (2022) |
|---|---|
| The United States | 35.2% |
| Germany | 5.7% |
| Japan | 6.0% |
| North America | 38.9% |
| Europe | 26.7% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 8.1% |
| India | 11.9% |
| The United Kingdom | 4.0% |
| Australia | 5.9% |
Growing Exposure to Air Pollution to Drive the Market in North America
The airway clearance devices system market in North America held a 35.2% revenue share in 2022. Growing collective efforts by the key players in North America to improve their product portfolio and to ensure high-quality standards are the factors that are anticipated to fuel the demand for airway clearance systems. Further, factors such as increasing air pollution and exposure to tobacco smoke, which triggers respiratory disorders, are also anticipated to accelerate the market growth over the analysis period.
The presence of stringent practice guidelines developed by the American Society of Anesthesiologists (ASA) and other healthcare organizations coupled with rising government initiatives are expected to boost the growth. For example, guidelines developed by the ASA for difficult airway management provide evidence-based intervention.
Growing Technological Innovations in Europe to Support the Market Growth in the Region
The airway clearance devices system market in Europe captured 26.7% of market revenue in 2022. Europe is anticipated to exhibit significant growth over the analysis period, attributed to continuous technological innovations, coupled with a rising market penetration of key players and expansion of their distribution networks.
According to the WHO, about 3 million people in Japan are affected by asthma out of which 30% have moderate and 7% have severe asthma. Furthermore, an increasing number of product approvals and commercial research and development activities are expected to fuel regional growth.
Increasing Prevalence of Genetic Diseases, Including CF to Drive Asia Pacific Market
As per Netwellness, a community service provider, 3 to 4% of babies are born with genetic disorders. This number is poised to rise in the coming years, especially in the emerging economies of Asia Pacific such as China and India owing to the high birth rate observed in these regions. As the number of cases of CF rises, so will the demand for CF treatment, thereby augmenting the growth of the airway clearance devices market in the Asia Pacific during the forecast period.
| Category | By Product Type |
|---|---|
| Leading Segment | High-frequency chest wall oscillation |
| Market Share (2022) | 58.7% |
| Category | By End User |
|---|---|
| Leading Segment | Hospitals |
| Market Share (2022) | 62.10% |
The Presence of Better Access to Medical Facilities in Hospitals Benefits the Segment
The hospitals and clinics segment is expected to dominate the market during the forecast period. This can be attributed to the factors such as the availability of advanced medications, antibiotics, antivirals, vaccinations, and others.
The hospitals and clinics segment is the large revenue-generating segment because of better access to healthcare services. Further, hospitals & medical practices are collaborating with insurance companies for better and fast reimbursement resulting in large patient footfall.
ABM Respiratory Care (Singapore), Sionna Therapeutics (USA), Morphic Therapeutic (USA), Galecto Biotech (Denmark), Kojin Therapeutics (USA), Lung Therapeutics (USA), Enterprise Therapeutics (United Kingdom), Inventiva (France), Trucode (USA), and NuvoAir (Sweden), are some of the emerging names in the global airway clearance devices system market. These market
players are attaining notable traction among the established players in the market. For instance,
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Most companies engage in strategic acquisitions, market expansions, and collaborative research initiatives to gain significant market share. A few of the Renowned players in the global airway clearance devices market include Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc., Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, and Thayer Medical, among others.
Recent Developments:
Key Players Profiled in the Market:
The market is valued at USD 624.5 million in 2023.
Allergan Plc., Dymedso Inc., and Electromed Inc. Ltd. are key market players.
The market will reach USD 1137.2 million by 2033.
Increasing cases of cystic fibrosis, and asthma, will drive the market prospects.
China is likely to expand at a CAGR of 8.1% through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Positive Expiratory Pressure 5.2. Intrapulmonary Percussive Ventilation 5.3. Oral High-Frequency Oscillation 5.4. High-Frequency Chest Wall Oscillation 5.5. Flutter 5.6. Incentive Spirometry 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Hospitals 6.2. Clinics 6.3. Ambulatory Surgical Centers 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Allergan Plc. 17.2. Dymedso Inc. 17.3. Electromed Inc. Ltd. 17.4. General Physiotherapy Inc. 17.5. Hill-Rom Holdings, Inc. 17.6. International Biophysical Corporation 17.7. Koninklijke Philips N.V. (Philips) 17.8. Monaghan Medical Corporation, Inc. 17.9. PARI GmbH 17.10. Thayer Medical 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Airway Clearance Devices System Market
